墨西哥電視 TV 深 滬
等待開盤 09-25 09:30:00 美东时间
2.391
-0.039
-1.60%
華盛通- 最 高2.435
- 今 開2.43
- 成交量 45.07万股
- 最 低 2.365
- 昨 收 2.43
- 總市值 25.48亿
- 52周最高 3.49
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 2.18
- 委 比 -36.12%
- 總股本 10.66亿
- 歷史最高 38.8615
- 量 比 0.23
- 振 幅 2.88%
- 歷史最低 1.4692
- 每 手 1
- 風險率 0.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多瑞银小幅上调墨西哥电视目标价 由3.1美元微调至3.2美元
经济观察网 墨西哥电视获瑞银小幅上调目标价，维持持有评级。机构观点：8月6日，瑞银维持"持有"评级，目标价从3.1美元微调至3.2美元，分析师Leonardo...
08-13 03:50
Grupo Televisa Renews Market Maker Agreement for Mexican Shares
Grupo Televisa, S.A.B. ( ($TV) ) just unveiled an announcement. On August 3, 20...
08-04 18:28
Grupo Televisa reports Q2 results
Grupo Televisa press release (TV): Q2 Revenue of Ps. 14.29B (-3.0% Y/Y). Net income or loss attributable to stockholders of the Company changed by Ps.971.9 million to a net loss of Ps.497.4 million in...
07-24 05:36
Grupo Televisa Q2 EPS $(0.05) Misses $0.01 Estimate, Sales $821.569M Miss $828.260M Estimate
Grupo Televisa (NYSE:TV) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.01 by 600 percent. This is a 200 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $821.569 million which ...
07-24 04:33
美股大行评级 | 高盛上调AMD目标价从450美元升至640美元；伯恩斯坦上调阿斯麦目标价从1971美元升至2623美元
今日重点评级关注：Roth Capital：维持Nuvectis Pharma"买入"评级，目标价从20美元升至33美元；摩根士丹利：维持GXO Logistics"超配"评级，目标价从75美元升至78美元
07-07 11:34
UBS Maintains Neutral on Grupo Televisa, Lowers Price Target to $3.1
UBS analyst Leonardo Olmos maintains Grupo Televisa (NYSE:TV) with a Neutral and lowers the price target from $3.2 to $3.1.
07-06 23:58
Benchmark refreshes 'best ideas' roster
Benchmark Research on Wednesday released its quarterly update to its "best ideas" list for July 2026, highlighting 31 of its analysts' highest-conviction, catalyst-driven stock picks across major mark...
07-01 21:35
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
UBS Maintains Neutral on Grupo Televisa, Lowers Price Target to $3.2
UBS analyst Leonardo Olmos maintains Grupo Televisa (NYSE:TV) with a Neutral and lowers the price target from $3.7 to $3.2.
05-12 04:33
